Pharmacy alerts

  • Benzylpenicillin benzathine powder for suspension for injection defect

    Class 4 medicines defect notification: Brancaster Pharma Limited, benzylpenicillin benzathine 1.2 million I.U. and 2.4 million I.U. powder for suspension for injection

    Read more

  • Personal protective equipment and heat: risk of heat stress

    Urgent public health message to healthcare providers and professionals regarding the risk of heat stress when using PPE.

    Read more

  • ACE-inhibitors: the distinction between bradykinin- and histamine-mediated angioedema

    The MHRA has published a drug safety update on ACE-inhibitors and the distinction between bradykinin- and histamine-mediated angioedema.

    Read more

  • Orbit Pharma Limited, cyclizine lactate 50mg/ml solution for injection recall

    The MHRA has published a class 3 medicines recall for cyclizine lactate 50mg/ml solution for injection.

    Read more

  • Cadila Pharmaceuticals Limited, mirtazapine 30mg tablets defect

    The MHRA has published a class 4 medicines defect notification for mirtazapine 30mg tablets.

    Read more

  • Teva UK Ltd, Ponlimsi (Denosumab) 60mg solution for injection in pre-filled syringe defect

    The MHRA has published a Class 4 medicines defect notification for Ponlimsi (denosumab) 60mg solution for injection in pre-filled syringe.

    Read more